Evercore ISI analyst Elizabeth Anderson lowered the firm’s price target on Rite Aid (RAD) to $0 from $1 and keeps an Underperform rating on the shares ahead of Q3 earnings from the healthcare tech and distribution group. In the group, the firm’s top picks include CVS Health (CVS), its top large cap pick, Iqvia (IQV) and R1 RCM (RCM), the analyst tells investors.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on RAD: